MX2014000753A - Procedimiento para producir antigeno viral y vacunas. - Google Patents

Procedimiento para producir antigeno viral y vacunas.

Info

Publication number
MX2014000753A
MX2014000753A MX2014000753A MX2014000753A MX2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A
Authority
MX
Mexico
Prior art keywords
viral antigen
enveloped virus
vaccines
producing viral
fluid
Prior art date
Application number
MX2014000753A
Other languages
English (en)
Spanish (es)
Inventor
Yi-Qing Cui
Yiding Wang
Jo Thus
Hof Ron Van T
Sabah Shaker
Geertje Jacoba Van Rooij
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Publication of MX2014000753A publication Critical patent/MX2014000753A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2014000753A 2011-07-20 2012-07-04 Procedimiento para producir antigeno viral y vacunas. MX2014000753A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
EP11174660 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (1)

Publication Number Publication Date
MX2014000753A true MX2014000753A (es) 2014-05-07

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000753A MX2014000753A (es) 2011-07-20 2012-07-04 Procedimiento para producir antigeno viral y vacunas.

Country Status (12)

Country Link
EP (1) EP2734619B1 (https=)
JP (1) JP6275641B2 (https=)
KR (2) KR20160096215A (https=)
CN (1) CN103827296B (https=)
AU (1) AU2012286098C1 (https=)
BR (1) BR112014001049A2 (https=)
CA (1) CA2841604C (https=)
ES (1) ES2653197T3 (https=)
MX (1) MX2014000753A (https=)
RU (1) RU2565827C2 (https=)
TW (1) TW201311896A (https=)
WO (1) WO2013010797A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104524563A (zh) * 2014-12-12 2015-04-22 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
WO2019121846A1 (en) 2017-12-19 2019-06-27 CSL Behring Lengnau AG Protein purification and virus inactivation with alkyl glycosides
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
IL279295B2 (en) 2018-06-12 2026-03-01 Kentucky Bioprocessing Inc Purification and cross-linking of virus and antigen
US11999975B2 (en) * 2018-07-04 2024-06-04 Probiogen Ag Method for purifying an enveloped virus
US12123028B2 (en) 2018-11-15 2024-10-22 Bayer Healthcare Llc Viral inactivation methods for continuous manufacturing of antibodies
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
MX2022005513A (es) * 2019-11-07 2022-06-08 Seqirus Uk Ltd Composiciones y metodos para producir una vacuna viral con tama?o de particula reducido.
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
JP7779858B2 (ja) * 2020-04-29 2025-12-03 エスケー バイオサイエンス カンパニー リミテッド 使い捨て培養工程システムを用いたインフルエンザウイルス生産方法及びインフルエンザウイルス抗原精製条件の迅速確認試験
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US7262045B2 (en) * 2003-02-25 2007-08-28 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Alachua Government Services, Inc. Method for producing viral vaccines
WO2009115917A2 (en) * 2008-03-18 2009-09-24 Novartis Ag Improvements in preparation of influenza virus vaccine antigens
CN102215865B (zh) * 2008-09-24 2013-10-30 米迪缪尼有限公司 病毒纯化方法
RU2547587C2 (ru) * 2008-09-24 2015-04-10 Медиммун, Ллк Способы культивирования клеток, размножения и очистки вирусов
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Also Published As

Publication number Publication date
AU2012286098A1 (en) 2014-01-23
JP6275641B2 (ja) 2018-02-07
CN103827296B (zh) 2016-11-16
EP2734619B1 (en) 2017-09-06
AU2012286098C1 (en) 2016-09-15
JP2014524747A (ja) 2014-09-25
WO2013010797A1 (en) 2013-01-24
CN103827296A (zh) 2014-05-28
TW201311896A (zh) 2013-03-16
RU2014101484A (ru) 2015-07-27
CA2841604C (en) 2020-01-21
RU2565827C2 (ru) 2015-10-20
CA2841604A1 (en) 2013-01-24
EP2734619A1 (en) 2014-05-28
ES2653197T3 (es) 2018-02-06
KR20140038530A (ko) 2014-03-28
BR112014001049A2 (pt) 2017-02-21
KR20160096215A (ko) 2016-08-12

Similar Documents

Publication Publication Date Title
MX2014000753A (es) Procedimiento para producir antigeno viral y vacunas.
PH12018500916A1 (en) Antibody neutralizing human respiratory syncytial virus
MX394097B (es) Producción de partículas similares a virus en plantas.
MX352338B (es) Anticuerpos neutralizantes del virus de la influenza a y usos de estos.
MX2010003202A (es) Metodo para producir virus de la gripe.
MY161965A (en) New influenza virus immunizing epitope
EA201490583A1 (ru) Удаление примесных вирусов из препаратов аав
MX354750B (es) PARTÍCULAS PSEUDO-VIRALES (PPVs) QUE COMPRENDEN GLICOPROTEÍNAS DEL VIRUS DE LA RABIA.
WO2010148511A8 (en) Chimeric influenza virus-like particles comprising hemagglutinin
FR2967072B1 (fr) Procede pour ameliorer la production de virus et semences vaccinales influenza
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX376138B (es) Produccion de particulas similares a virus de influenza en plantas.
EA201400216A1 (ru) Консервирование биологических продуктов, в частности вакцин, с применением вакуума
EP2873423A3 (en) Soluble hiv-1 envelope glycoprotein trimers
PH12014500640A1 (en) Increasing virus-like particle yield in plants
MX2013013228A (es) Particulas similares a virus y proceso para prepararlas.
GEP20227351B (en) Preparation of solid dosage forms comprising antibodies by solution/suspension layering
WO2013055326A3 (en) Vaccines for human papilloma virus and methods for using the same
EA201592298A1 (ru) Полуживая вирусная вакцина против респираторно-синцитиального вируса
MY183980A (en) Commercial scale process for production of prrsv
EP2484757A4 (en) VIRUS FOR THE EXPRESSION OF ALPHA GALACTOSE EPITOPES AND METHOD FOR THE PRODUCTION OF A VACCINE
IN2015DN02772A (https=)
PH12013501794A1 (en) Preparation method of new recombinant antibacterial polypeptide medicine
CU20150019A7 (es) Rotavirus humanos modificados
PH12012502273A1 (en) Marker vaccine for classical swine fever

Legal Events

Date Code Title Description
FA Abandonment or withdrawal